Morgan L. Maeder, et al. Therapeutic Correction of an LCA-Causing Splice Defect in the CEP290 Gene by CRISPR/Cas-Mediated Genome Editing. Presented at the Association for Research in Vision and Ophthalmology (ARVO), May 1-5, 2016 in Seattle, WA.

Jan

10

Editas Medicine Reports on Recent Progress and Outlook at J.P. Morgan Healthcare Conference

Jan

4

Editas Medicine to Present at the 40th Annual J.P. Morgan Healthcare Conference

Dec

20

Editas Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for EDIT-301 for the Treatment of Transfusion-Dependent Beta Thalassemia